You're last point isn't correct and was a non issue in due diligence. Skip pulled out as they didn't have the funding to go ahead as Stonepeak pulled the pin given the risk around the MAT (from memory ended up being $10-$15m plus delays which basically ruin an infra PE shops IRRs and thus the deal - they would of baked in contingency on top of that too as they don't have the benefit of hindsight).
- Forums
- ASX - By Stock
- GNX
- Ann: Genex receives NBIO from J-POWER
Ann: Genex receives NBIO from J-POWER, page-72
-
- There are more pages in this discussion • 30 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)